Making continuing appropriations for fiscal year 2024, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The Continuing Appropriations Act, 2024 keeps the federal government running through November 17, 2023, by extending funding at fiscal year 2023 levels. It also includes $16 billion in emergency disaster relief funding for FEMA and extends several expiring federal programs including FDA user fees, FAA airport funding, and public health programs.
Who Benefits and How
Federal employees benefit by avoiding furloughs through continued government funding. Disaster victims receive $16 billion in FEMA relief for ongoing recovery efforts. Community health centers receive $526 million to continue serving underserved communities. Wildland firefighters continue receiving their salary increases. WIC participants, SNAP recipients, TANF families, and rural housing assistance recipients all maintain their benefits. Columbia-class submarine contractors (General Dynamics and Huntington Ingalls) receive $621 million for continued procurement.
Who Bears the Burden and How
Animal drug manufacturers pay $33.5 million annually in user fees to FDA through 2028. Generic animal drug manufacturers pay $25 million annually. Airlines and air travelers continue paying aviation fuel and ticket taxes through year-end. Taxpayers fund the $16 billion in disaster relief. Defense contractors face restrictions on new projects since DoD cannot initiate work not funded in FY2023.
Key Provisions
- Continues all federal agency funding at FY2023 rates through November 17, 2023
- Appropriates $16 billion for FEMA disaster relief, designated as emergency spending
- Provides $842 million for Airport Improvement Program and extends FAA authorities through December 31, 2023
- Reauthorizes FDA animal drug and generic animal drug user fee programs for FY2024-2028
- Extends community health center funding ($526M), National Health Service Corps ($40.8M), and teaching health centers ($16.6M)
- Authorizes $621 million for Columbia-class submarine procurement despite CR restrictions
- Continues TANF, child welfare, and sex education programs through the CR period
- Extends Compact of Free Association provisions with Micronesia and Marshall Islands
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Provides temporary government funding and program extensions through November 17, 2023, preventing a government shutdown by continuing FY2023 appropriations at existing rates while extending specific program authorities and user fee collections.
Who Benefits
- Federal employees (avoiding furloughs through continued funding)
- Animal drug manufacturers (extended user fee framework provides predictable regulatory pathway)
- Commercial aviation industry (extended FAA authorities and Airport Improvement Program funding)
Who Bears Costs
- Animal drug and generic animal drug manufacturers (continued user fees totaling ~58.5M annually)
- Hospitals in certain states (delayed DSH payment reductions)
- Medicaid drug manufacturers (reduced MIF threshold by ~643M)
Key Policy Areas
Federal Appropriations, Government Operations, Aviation, FDA Drug Regulation, Public Health, Social Services, Disaster Relief, Agriculture, International Relations
Primary Purpose
Provides temporary government funding and program extensions through November 17, 2023, preventing a government shutdown by continuing FY2023 appropriations at existing rates while extending specific program authorities and user fee collections.
Policy Domains
Legislative Strategy
"Short-term continuing resolution to maintain government operations while Congress negotiates full-year appropriations, bundled with program reauthorizations that would otherwise expire"
Identified Gains
- Federal employees (avoiding furloughs through continued funding)
- Animal drug manufacturers (extended user fee framework provides predictable regulatory pathway)
- Commercial aviation industry (extended FAA authorities and Airport Improvement Program funding)
- Community health centers (continued mandatory funding)
- Disaster victims (16 billion in additional FEMA disaster relief)
- Pacific Island nations (continued Compact of Free Association programs)
Identified Costs
- Animal drug and generic animal drug manufacturers (continued user fees totaling ~58.5M annually)
- Hospitals in certain states (delayed DSH payment reductions)
- Medicaid drug manufacturers (reduced MIF threshold by ~643M)
Sponsors
Legislative Progress
IntroducedMs. Granger introduced the following bill; which was referred to …
Received
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Department of Defense, FDA, Federal agencies
Federal agencies faces effects in multiple directions
Positive-direction: FDA, Federal budget process, Federal civilian employees, Federal employees across all agencies, Federal government departments and agencies, Federal wildland firefighters, Micronesia and Marshall Islands, State Department
Negative-direction: Department of Defense, OMB
Animal drug manufacturers, Animal drug manufacturers with pending apps, Generic animal drug manufacturers
Positive-direction: Animal drug manufacturers with pending apps, Generic animal drug manufacturers with pending apps
Negative-direction: Animal drug manufacturers, Generic animal drug manufacturers
Low-income seniors, SNAP program participants, WIC participants
Disaster relief recipients, Disaster victims, Disaster-affected communities
Airlines, Airports
Positive-direction: Airports
Negative-direction: Airlines
State PREP programs, State abstinence education programs
Farmers and ranchers, Livestock packers
Positive-direction: Farmers and ranchers
Negative-direction: Livestock packers
DC government, States and grantees
Positive-direction: DC government
Negative-direction: States and grantees
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_director"
- → Director of the Office of Management and Budget
- "the_president"
- → President of the United States
- "the_secretary"
- → Varies by referenced appropriations act
- "the_secretary"
- → Secretary of Transportation
- "the_administrator"
- → Administrator of the Federal Aviation Administration
- "the_secretary"
- → Secretary of Health and Human Services
- "the_secretary"
- → Secretary of Health and Human Services
- "the_secretary"
- → Secretary of Health and Human Services
Note: 'The Secretary' refers to different Cabinet officials depending on the division: Secretary of Transportation in FAA sections, Secretary of HHS in FDA and public health sections
Key Definitions
Terms defined in this bill
Includes activities for mutual recognition agreements with EU and UK for pharmaceutical good manufacturing practice inspections
November 17, 2023 - the date through which continuing appropriations are available
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology